Mirataz Transdermal Ointment for Cats (2.0%)

Mirataz (mirtazapine transdermal ointment) is the first and only veterinary-approved medication specifically designed for the management of unintentional weight loss in cats. It acts as an appetite stimulant by utilizing mirtazapine, a compound that targets specific receptors in the brain to trigger the desire to eat. This ointment is formulated for transdermal absorption, allowing the medication to enter the bloodstream directly through the skin. This delivery method is particularly beneficial for feline patients that are difficult to pill or are experiencing nausea, ensuring they receive necessary nutritional support without the stress of oral administration.

Key Information

• Active Ingredient: Mirtazapine (2.0%).

• Approved Species: Cat.

• Uses: Management of weight loss in cats experiencing poor appetite due to various medical conditions.

• Form: Transdermal Ointment.

• Route of Administration: Topical (applied to the inner surface of the ear/pinna).

Prescription Required

Mirataz is a prescription-only medication. A valid prescription from a licensed veterinarian is required for purchase. Professional diagnosis is necessary to identify the underlying cause of a cat's weight loss before starting treatment. Because this medication is absorbed through the skin, pet owners should wear gloves or wash their hands thoroughly after application to prevent accidental exposure.